• Explore /
  • Poster
  • / Phase II study with immunotherapy with dendritic cells (DC) and intratumoral hiltonol in patients with advanced solid tumors.

Phase II study with immunotherapy with dendritic cells (DC) and intratumoral hiltonol in patients with advanced solid tumors.

Abstract Poster

Authors

null

José María López-Picazo

Department of Oncology. Clinica Universidad de Navarra, Pamplona, Spain

José María López-Picazo , Carlos Alfaro , Jose Luis Perez-Gracia , Maria Rodriguez-Ruiz , Alfonso Gurpide , Miguel Fernandez de Sanmamed , Salvador Martin-Algarra , Alberto Benito , David Cano , Alvaro Gonzalez , Inmaculada Rodriguez , Juan Pablo Fusco , Rafael Martinez-Monge , Ignacio Melero

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics - Immunotherapy

Track

Developmental Therapeutics

Sub Track

Immunotherapy and Biologic Therapy

Clinical Trial Registration Number

NCT01734564

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr TPS3113)

DOI

10.1200/jco.2014.32.15_suppl.tps3113

Abstract #

TPS3113

Poster Bd #

179A

Abstract Disclosures

Similar Posters

First Author: Javier Rodriguez

First Author: Alexey Viktorovich Novik

First Author: Hiroya Taniguchi

First Author: Bradley Corr